Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design
I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, Y. Hwa, A. Fonder, M. Hobbs, S. Hayman, T. Kourelis, R. Warsame, E. Muchtar, N. Leung, P. Kapoor, M. Grogan, R. Go, Y. Lin, W. Gonsalves, M. Siddiqui, R. A. Kyle, S. V. Rajkumar, M. A. Gertz, A. Dispenzieri
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAmyloidosis: Diagnosis, Treatment, Outcomes
Correction to: Leukemia 10.1038/s41375-021-01297-z, published online 21 May 2021
The Funding information section was missing from this article and should have read ‘This work was supported by the Paul Calabresi K12 Career Development Award (CA90628-21) and in part by Grant Number P30 CA015083 and CA186781 from the National Cancer Institute and by the Predolin Foundation and the JABBS Foundation.’.
The original article has been corrected.